Selected Reads

Smartkarma

Equity Bottom-Up

Shadow Realm is the magical, coming-of-age tale of Arya, a fifteen-year-old boy who is tormented by demons. Anything to do with his ethnicity, food, traditions or the fascinating mythological stories he has been raised with, has become the building block of unpleasant school experiences. In the wake of an accident that confines his once-vibrant mother to a hospital ward, kept alive by tubes and machines, Arya clings to the only remnant of their bond: an old, battered copy of the Ramayana,…

Join TC and Georgia for Gabriel Grego's return visit to The Chartcast where he discusses the accusations he's made against Penumbra (NYSE: PEN) for releasing a fatally flawed medical device into the market, the company's response, and what is next in his crusade against the company's management team.The Chartcast is listener-supported! Your support for The Chartcast is a vote for deep, intellectual discussion that shines a disinfecting light on the the topics of the day. Thank…

United States

Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00